GDF15 is a divergent member of the transforming growth factor- (TGF) superfamily
Safety of glucagon-like peptide-1 receptor agonists: a real-world study based on the US FDA Adverse Event Reporting System Database
We do not endorse or prescribe compounded medications, given their lack of reliability in quality and testing
Active Malignancy: Because growth hormone can promote cell proliferation, sermorelin is contraindicated in patients with active cancers or tumors
Absolute stereostructure of potent -glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata
Growth hormone-related adverse effects : Sermorelin may cause edema, arthralgia, paresthesia (including carpal tunnel syndrome), and glucose intolerance through GH stimulation